Skip to main content
. 2015 Nov;21(11):10.18553/jmcp.2015.21.11.1054. doi: 10.18553/jmcp.2015.21.11.1054

TABLE 1.

Baseline Characteristics of Study Population

  Prevalent Atrial Fibrillation Incident Atrial Fibrillation
Follow-up Period 6 Months 9 Months 12 Months 6 Months 9 Months 12 Months
Number of patients 2,893 1,713 768 408 238 96
Age, mean (SE) 63.0 (11.6) 63.0 (11.6) 63.0 (11.6) 64.4 (11.6) 65.2 (12.3) 65.0 (12.5)
Age, n (%)
  18-44 116 (4.0) 66 (3.9) 32 (4.2) 16 (3.9) 9 (3.8) 4 (4.2)
  45-64 1,733 (59.9) 1,034 (60.4) 469 (61.1) 217 (53.2) 126 (52.9) 52 (54.2)
  65-74 552 (19.1) 320 (18.7) 141 (18.4) 97 (23.8) 51 (21.4) 17 (17.7)
  75+ 492 (17.0) 293 (17.1) 126 (16.4) 78 (19.1) 52 (21.8) 23 (24.0)
Gender, n (%)
  Male 1,999 (69.1) 1,211 (70.7) 554 (72.1) 309 (75.7) 176 (73.9) 65 (67.7)
  Female 894 (30.9) 502 (29.3) 214 (27.9) 99 (24.3) 62 (26.1) 31 (32.3)
Region of residence, n (%)
  East 295 (10.2) 164 (9.6) 88 (11.5) 38 (9.3) 25 (10.5) 11 (11.5)
  Midwest 901 (31.1) 557 (32.5) 274 (35.7) 129 (31.6) 73 (30.7) 33 (34.4)
  South 1,394 (48.2) 806 (47.1) 315 (41.0) 201 (49.3) 116 (48.7) 46 (47.9)
  West 303 (10.5) 186 (10.9) 91 (11.8) 40 (9.8) 24 (10.1) 6 (6.3)
CHADS2, mean (SE) 1.47 (1.13) 1.44 (1.09) 1.43 (1.08) 1.53 (1.12) 1.52 (1.05) 1.69 (1.05)
CHADS2, n (%)
  0 557 (19.3) 332 (19.4) 145 (18.9) 77 (18.9) 41 (17.2) 12 (12.5)
  1 1,089 (37.6) 651 (38.0) 302 (39.3) 131 (32.1) 78 (32.8) 30 (31.3)
  2 776 (26.8) 465 (27.1) 209 (27.2) 138 (33.8) 85 (35.7) 36 (37.5)
  3 314 (10.9) 184 (10.7) 80 (10.4) 36 (8.8) 23 (9.7) 12 (12.5)
  4 117 (4.0) 64 (3.7) 23 (3.0) 22 (5.4) 10 (4.2) 6 (6.3)
  5 37 (1.3) 16 (0.9) 8 (1.0) 4 (1.0) 1 (0.4) 0 (0.0)
  6 3 (0.1) 1 (0.1) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0)

Source: IMS Health LifeLink Health Plan Claims Database, 2010-2012.23

Note: 12-month and 9-month cohorts were derived from the 6-month cohort.

SE = standard error.